Dow Up 0.01% Nasdaq Down 0.06%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
2.08 Down 0.03(1.42%) 1:23PM EDT - Nasdaq Real Time Price
Prev Close:2.11
Open:2.10
Bid:2.08 x 2100
Ask:2.09 x 4700
1y Target Est:5.91
Beta:1.08
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:2.07 - 2.13
52wk Range:1.66 - 7.77
Volume:439,026
Avg Vol (3m):2,074,350
Market Cap:245.88M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALE

Comparison

Symbol% ChgMkt Cap
GALEDown 1.42%245.88M
CELGDown 0.89%75.79B
VSTMUp 1.16%224.83M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology treatments that address major unmet medical needs to advance cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback